Flerie AB Stock: price and insider trades · Sweden

Flerie AB is a Health Care company. Its directors and officers file their transactions with Finansinspektionen. Between 18 October 2025 and 18 October 2026, 5 insiders published 14 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

There has been no open-market purchase by an insider of Flerie AB for at least a year. Most trades are made public on the day they happen. For comparison, MAR article 19 gives managers three business days to notify a trade.

Compared with its exchange (885 companies, median 7 filings), a count of 14 filings is above the norm. The full history, which starts in 2025, counts no purchases against 1 sale.

Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.